Vera Therapeutics
VERA
VERA
160 hedge funds and large institutions have $2.21B invested in Vera Therapeutics in 2024 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 51 increasing their positions, 32 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
2.44% more ownership
Funds ownership: 95.3% → 97.73% (+2.4%)
62% less call options, than puts
Call options by funds: $6.1M | Put options by funds: $16M
Holders
160
Holding in Top 10
7
Calls
$6.1M
Puts
$16M
Top Buyers
| 1 | +$227M | |
| 2 | +$103M | |
| 3 | +$52.1M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$36.1M |
| 5 |
SC
Samlyn Capital
New York
|
+$27.8M |
Top Sellers
| 1 | -$98.5M | |
| 2 | -$91.6M | |
| 3 | -$67.3M | |
| 4 |
O
OrbiMed
New York
|
-$36.3M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
-$32.7M |